ABUS
Arbutus Biopharma Corporation (ABUS)
$
43About Arbutus Biopharma Corporation (ABUS)
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.
Details
Daily high
$3.45
Daily low
$3.33
Price at open
$3.41
52 Week High
$4.72
52 Week Low
$2.30
Market cap
650.0M
Dividend yield
0.00%
Volume
734,897
Avg. volume
705,448
P/E ratio
-8.05
Arbutus Biopharma Corporation News
Details
Daily high
$3.45
Daily low
$3.33
Price at open
$3.41
52 Week High
$4.72
52 Week Low
$2.30
Market cap
650.0M
Dividend yield
0.00%
Volume
734,897
Avg. volume
705,448
P/E ratio
-8.05